Altimmune Shares Fall Despite Fatty Liver Disease Study Meets Primary Goal
Altimmune Inc (NASDAQ:ALT) shares plunged after topline results from its 12-week Phase 1b study of pemvidutide in subjects with non-alcoholic fatty…
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
Pfizer Inc (NYSE:PFE) has dosed the first participants in the Phase 3 trial of its quadrivalent modified RNA (modRNA) influenza vaccine…
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
Bayer AG (OTC:BAYRY) has started a hunt for CEO Werner Baumann’s successor, Bloomberg News reported, citing people close to the…
Bill Gates Has Humorous Take On Why He Became Global Target of Conspiracy Theorists: ‘They Didn’t Know’ Who Fauci Was
Microsoft Corp. (NASDAQ: MSFT) co-founder Bill Gates had to face backlash from conspiracy theorists during the COVID-19 pandemic. In a new interview, the billionaire talked about his reaction to it, how he handled the situation.
BrainsWay Announces Private Insurance Coverage From Cigna Corporation For Treatment Of OCD Utilizing Deep TMS
BURLINGTON, Mass. and JERUSALEM, Israel, Sept. 14, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiveBURLINGTON, Mass. and JERUSALEM, Israel, Sept. 14, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd.
NGM Bio Presents Preliminary Data From NGM120 Combo Trial In Pancreatic Cancer
NGM Biopharmaceuticals Inc (NASDAQ:NGM) announced updated preliminary findings from its Phase 1b dose escalation trial of NGM120 in metastatic pancreatic cancer.…
Important Biotech Catalysts For September 13, 2022 – End Of The Day Summary
Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety…
GENFIT Gets FDA Orphan Drug Status For Liver Disease Candidate
The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to GENFIT’s (NASDAQ: GNFT) drug candidate GNS5611 (ezurpimtrostat) for the treatment of cholangiocarcinoma.
Biden Administration Pushes ‘Cancer Moonshot’ Initiative: Report
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it."
The President underscored his goal to cut the cancer death rate in the U.S. by at least 50% over the next 25 years.
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati